Pershing Square Sohn Cancer Research Alliance Prize For Young Investigators

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Pershing Square Sohn Cancer Research Alliance is taking applications for its Prize for Young Investigators in Cancer Research.

The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue research at a stage when traditional funding is lacking. Each prize winner is also given a mentor in the pharmaceutical industry and the opportunity to present his or her work to scientific and business audiences.

In May 2015, PSSCRA awarded the prize to six winners: Timothy Chan, of Memorial Sloan Kettering Cancer Center; Arvin Dar, of the Icahn School of Medicine at Mount Sinai; Evripidis Gavathiotis, of Albert Einstein College of Medicine; Moritz Kircher, of MSKCC; Christine Mayr, of MSKCC; and Sohail Tavazoie, of The Rockefeller University.

In order to apply, applicants must have between two and eight years of experience running their own laboratories and must have a Ph.D., M.D., or M.D.-Ph.D. or equivalent. The deadline to submit a letter of intent is Nov. 9.

More details on the application process, including full eligibility criteria, are available on their website.

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login